Scribd Logo
Upload

Welcome to Scribd!

  • 671 views

    Pharmanex Clinical Studies

    Uploaded by

    Roma Agsalud
    A clinical study found that women who took 500mg of Pharmanex Tegreen 97 supplement twice daily for two years self-reported reductions in pore size and increased skin evenness after 12 months, and physicians observed reduced appearance of small blood vessels and solar damage on the skin at 6 and 12 months, compared to baseline. A two-year study published in the Dermatological Surgery Journal showed that 47% of individuals taking Tegreen 97 had moderate or greater improvements in photoaging of the skin at 24 months versus the placebo group, as assessed by a blinded dermatologist.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOC, PDF, TXT or read online from Scribd

    Pharmanex Clinical Studies

    Uploaded by

    Roma Agsalud
    671 views2 pages
    A clinical study found that women who took 500mg of Pharmanex Tegreen 97 supplement twice daily for two years self-reported reductions in pore size and increased skin evenness after 12 months, and physicians observed reduced appearance of small blood vessels and solar damage on the skin at 6 and 12 months, compared to baseline. A two-year study published in the Dermatological Surgery Journal showed that 47% of individuals taking Tegreen 97 had moderate or greater improvements in photoaging of the skin at 24 months versus the placebo group, as assessed by a blinded dermatologist.

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    DOC, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    A clinical study found that women who took 500mg of Pharmanex Tegreen 97 supplement twice daily for two years self-reported reductions in pore size and increased skin evenness after 12 months, and physicians observed reduced appearance of small blood vessels and solar damage on the skin at 6 and 12 months, compared to baseline. A two-year study published in the Dermatological Surgery Journal showed that 47% of individuals taking Tegreen 97 had moderate or greater improvements in photoaging of the skin at 24 months versus the placebo group, as assessed by a blinded dermatologist.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOC, PDF, TXT or read online from Scribd
    Download as doc, pdf, or txt
    671 views2 pages

    Pharmanex Clinical Studies

    Uploaded by

    Roma Agsalud
    A clinical study found that women who took 500mg of Pharmanex Tegreen 97 supplement twice daily for two years self-reported reductions in pore size and increased skin evenness after 12 months, and physicians observed reduced appearance of small blood vessels and solar damage on the skin at 6 and 12 months, compared to baseline. A two-year study published in the Dermatological Surgery Journal showed that 47% of individuals taking Tegreen 97 had moderate or greater improvements in photoaging of the skin at 24 months versus the placebo group, as assessed by a blinded dermatologist.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOC, PDF, TXT or read online from Scribd
    Download as doc, pdf, or txt
    of 2

    Clinical Study Results Show Pharmanex Tegreen 97 Benefits the Skin.

    Women who took Tegreen 97 twice daily for two years reported the following over baseline:

    Reduction in pore size at 12 months Increased skin evenness at 12 months

    Women who took Tegreen 97 twice daily for two years were graded by physicians who reported the following over baseline:

    Reduced appearance of small blood vessels on the skins surface at 6 and 12 months Reduced solar damage at 6 months

    A two-year clinical study in the Dermatological Surgery Journal was recently published with results that show improved skin health when supplementing with 500mg Pharmanex Tegreen 97 daily.* The clinical study revealed a strong correlation between Pharmanex Tegreen 97 and reductions in skin damage based on multiple study assessments. 47% of individuals within the Pharmanex Tegreen 97 group had MODERATE OR GREATER IMPROVEMENTS IN PHOTOAGING at 24 months compared to placebo as graded by a blinded dermatologist.

    You might also like